Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/tid.13353 http://scihub22266oqcxt.onion/10.1111/tid.13353 32500942!7300527!32500942     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transpl+Infect+Dis 2020 ; 22 (5): e13353 Nephropedia Template TP {{tp|p=32500942|t=2020. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy |pdf=|usr=}}{{32500942}} gab.com Text Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy JO: Transpl Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32500942 #FOAvip Covid-19 pandemic is deeply affecting transplant activity worldwide. It is unclear whether solid organ transplant recipients are at increased risk of developing severe complications and how they should be managed, also concerning immunosuppression. This is a report about the course and management of SARS-CoV-2 infection in liver transplant recipients from a single center in Northwestern Italy in the period March-April 2020. Three patients who were treated at our institution are reported in detail, whereas summary data are provided for those managed at peripheral Hospitals. Presentation varied from asymptomatic to rapidly progressive respiratory failure due to bilateral interstitial pneumonia. Accordingly, treatment and changes to immunosuppression were adapted to the severity of the disease. Overall mortality was 20%, whereas Covid-related mortality was 10%. Two cases of prolonged (>2 months) viral carriage were observed in two asymptomatic patients who contracted the infection in the early course after transplant. Besides depicting Covid-19 course and possible treatment scenarios in liver transplant patients, these cases are discussed in relation to the changes in our practice prompted by Covid-19 epidemic, with potential implications for other transplant programs. Twit Text FOAVip Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy ????Transpl Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32500942 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32500942 #FOAvip English Wikipedia <ref>{{Cite pmid|32500942}}</ref> Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy #MMPMID32500942 Patrono D; Lupo F; Canta F; Mazza E; Mirabella S; Corcione S; Tandoi F; De Rosa FG; Romagnoli R Transpl Infect Dis 2020[Oct]; 22 (5): e13353 PMID32500942show ga Covid-19 pandemic is deeply affecting transplant activity worldwide. It is unclear whether solid organ transplant recipients are at increased risk of developing severe complications and how they should be managed, also concerning immunosuppression. This is a report about the course and management of SARS-CoV-2 infection in liver transplant recipients from a single center in Northwestern Italy in the period March-April 2020. Three patients who were treated at our institution are reported in detail, whereas summary data are provided for those managed at peripheral Hospitals. Presentation varied from asymptomatic to rapidly progressive respiratory failure due to bilateral interstitial pneumonia. Accordingly, treatment and changes to immunosuppression were adapted to the severity of the disease. Overall mortality was 20%, whereas Covid-related mortality was 10%. Two cases of prolonged (>2 months) viral carriage were observed in two asymptomatic patients who contracted the infection in the early course after transplant. Besides depicting Covid-19 course and possible treatment scenarios in liver transplant patients, these cases are discussed in relation to the changes in our practice prompted by Covid-19 epidemic, with potential implications for other transplant programs. |*COVID-19 Drug Treatment[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antiviral Agents/administration & dosage[MESH] |COVID-19 Testing[MESH] |COVID-19/diagnosis/immunology/*mortality[MESH] |Drug Therapy, Combination/methods[MESH] |Female[MESH] |Graft Rejection/immunology/prevention & control[MESH] |Humans[MESH] |Hydroxychloroquine/administration & dosage[MESH] |Immunocompromised Host[MESH] |Immunosuppressive Agents/*adverse effects[MESH] |Italy/epidemiology[MESH] |Liver Transplantation/*adverse effects[MESH] |Male[MESH] |Middle Aged[MESH] |SARS-CoV-2/*immunology/isolation & purification[MESH]Outcome of COVID-19 in liver transplant recipients: A preliminary repo(epmc).pdf DeepDyve Pubget Overpricing